1
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15[d] of
The Securities Exchange Act of 1934
DATE OF REPORT [Date of earliest event reported]: March 11, 1998
LASER VISION CENTERS, INC.
[Exact name of Issuer as specified in its charter]
Delaware 33-33843 43-153003
[State or other [Commission [IRS Employer
jurisdiction of File Number] Identification
incorporation] Number]
540 Maryville Centre Drive, Suite 200
St. Louis, Missouri 63141
[Address of Principal Executive Offices]
Issuer's telephone number: [314] 434-6900
2
FORM 8-K
ITEM 5. OTHER EVENTS
On March 11, 1998, the Company was served with a subpoena by the United
States Department of Justice. The Company understands that the subpoena is part
of an industry-wide investigation regarding the international card, compact
disc software that enables excimer lasers to be used to perform laser eye
surgeries for higher myopia cases (greater than - 6.0 diopters) than were
initially approved by the FDA. The FDA approved use of excimer lasers for
higher myopia cases in January, 1998. The Company intends to cooperate fully
with the Department of Justice.
On March 16, 1998, the Company issued a press release pertaining to the
subpoena. A copy of that press release is attached hereto as an exhibit.
ITEM 7(c). LIST OF EXHIBITS FILED
99.1 Press Release
2
3
FORM 8-K
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LASER VISION CENTERS, INC.
BY: /s/ John J. Klobnak
----------------------------
John J. Klobnak
Chief Executive Officer
Date: March 17, 1998
3